Tecelra Prices, Coupons, Copay Cards & Patient Assistance
Tecelra (afamitresgene autoleucel) is a member of the miscellaneous antineoplastics drug class and is commonly used for Synovial Sarcoma.
The cost for Tecelra - intravenous suspension is around $776,097 for a supply of 1 suspension, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Tecelra prices
Intravenous Suspension
Tecelra intravenous suspension
from $776,097.04
for 1 suspension
Quantity | Per unit | Price |
---|---|---|
1 | $776,097.04 | $776,097.04 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tecelra Coupons, Copay Cards and Rebates
Tecelra offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Tecelra Copay Assistance Program
Eligible patients may save on copays with Adaptimmune Assist.
- Applies to:
- Tecelra
- Number of uses:
- Per length of program
Form more information phone: 855-246-9232 or Visit website
Patient Assistance & Copay Programs for Tecelra
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: AdaptimmuneAssist
Eligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- This program is intended for US HEALTHCARE PROFESSIONALS and/or Professionals involved in Healthcare Reimbursement ONLY; Co-payment and patient support available for eligible patients
- Tecelra (afamitresgene autoleucel) Suspension; IV
More information please phone: 855-246-9232 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Adstiladrin
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Aucatzyl
Aucatzyl is a CAR-T cell treatment for acute lymphoblastic leukemia (ALL) in adults that is made by ...
More about Tecelra (afamitresgene autoleucel)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español